Novartis launches chronic disease programme for poor countries
Drugmaker Novartis AG has begun a programme in Kenya, Ethiopia and Vietnam to supply 15 low-cost medicines to fight chronic diseases like diabetes and high blood pressure.
The Swiss-based pharmaceuticals group said on 24 September its scheme would supply drugs for just $1 per treatment per month to governments, aid groups and others for a range of conditions that also includes cardiovascular and respiratory disease.
